Efficacy and Safety of Oral Cashew Nut Immunotherapy in Children (CAJESITO)

Central Hospital, Nancy, France

Status: Not yet enrolling

Conditions: Allergy;Food; Allergy, Nut

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT05826405

FORM-03935

Details and patient eligibility

About

The objectives of the CAJESITO study are (i) to assess the tolerance of oral cashew nut immunotherapy, by describing the frequency and severity of allergic reactions during oral cashew nut immunotherapy and (ii )to assess the risk factors for severe allergic reactions during oral cashew nut immunotherapy (predictive factors, associated factors.

Enrollment: 40 estimated patients

Sex: All

Ages: Under 18 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients under the age of 18 with a proven allergy to cashew nuts and followed in the pediatric allergology unit of the University Hospital of Nancy.
• Patients who have received oral cashew nut immunotherapy for at least 18 months as of 02/28/2023

Exclusion criteria

• Patients who have received oral cashew nut immunotherapy for less than 18 months.
• Patients lost to follow-up for more than 3 years, i.e. last consultation dating from 2020 or earlier

Trial design

40 participants in 1 patient group

Cashew Nut allergic

Treatment:

Other: No intervention